Canbi  Pharma  Tech  Cyfyngedig
1223403-58-4 larotrectinib
1223403-58-4 Larotrectinib
1223403-58-4 Larotrectinib

1223403-58-4 larotrectinib

Cas: 1223403-58-4
MF: C21H22F2N6O2
MW: 428.44
Einecs:
MDL Rhif:MFCD28902192

Anfon ymchwiliad
Disgrifiad

Eiddo

Ymddangosiad melyn solid
Dwysedd 1.55 ± 0. 1 g/cm3
Temp Storio. Rt
hydoddedd hydawdd yn DMSO (hyd at 5 mg/ml).
PKA8.41 ± 0. 40
 

Cais:

Mae larotrectinib yn atalydd TRK hynod ddetholus sy'n targedu tiwmorau ag ymasiad genynnau NTRK yn benodol ac yn arddangos effeithiau ataliol sylweddol.

 

Cyfystyron:

LarotrectiniB

1223403-58-4

(S) -n-(5- ((r) -2- (2, 5- difluorophenyl) pyrrolidin -1- yl) pyrazol o [1, 5- a] pyrimidin -3- yl) -3- hydroxypyrrolidine -1- carboxamide

Loxo 101

Vitrakvi

(3s) -n-[5- [(2r) -2- (2, 5- difluorophenyl) pyrrolidin -1- yl] pyrazol o [1, 5- a] pyrimidin -3- yl] -3- hydroxypyrrolidine -1- carboxamide

1- pyrrolidinecarboxamide, N-[{5- [(2r) -2- (2, 5- difluorophenyl) -1- pyrrolidinyl] pyrazolo [1, {5-}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} a] (3s)-

Larotrectinib (loxo -101 sylfaen am ddim)

1- pyrrolidinecarboxamide, N-(5- ((2r) -2- (2, 5- difluorophenyl) -1- pyrrolidinyl) pyrazolo (1, {5-}}}}}}}}} a) (3s)-

larotrectinibum

(3s) -n-(5- ((2r) -2- (2, 5- difluorophenyl) pyrrolidin -1- yl) pyrazol o (1, 5- a) pyrimidin -3- yl) -3- hydroxypyrrolidine -1- carboxamide

Larotrectinib (safonol)

Arry -470; larotrectiniB

C21H22F2N6O2

(3s) -n-(5- ((2r) -2- (2, 5- difluorophenyl) pyrrolidin - 1- yl) pyrazol O (1, 5- a) pyrimidin -3- yl) -3- hydroxypyrrolidine - 1- carboxamide

(3s) -n-(5- ((2r) -2- (2, 5- difluorophenyl) pyrrolidin -1- yl) pyrazol o (1, 5- a) pyrimidin -3- yl) -3- hydroxypyrrolidine - 1- carboxamide

(3s) -n-(5- (2- (2, 5- difluorophenyl) pyrrolidin -1- yl) pyrazolo (1, 5- a) pyrimidin -3- yl) -3- hydroxypyrrolidine -1- carboxamide

 

Tagiau poblogaidd: 1223403-58-4 larotrectinib, China 1223403-58-4 gweithgynhyrchwyr larotrectinib, cyflenwyr

Inquiry
goTop

(0/10)

clearall